-
Founded in:
2011-04-11 -
Country:
China -
Address:
West side of Yanbin Road, Feixian Economic Development Zone -
Tax NO.:
913713255728813685 -
Registered Funds:
50 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Gemcitabine hydrochloride |
Extract from the above information
More
Extract from the above information |
122111-03-9 | 62 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Nifuratel |
Pharmacological action not specified
More
Pharmacological action not specified |
4936-47-4 | 13 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ambroxol hydrochloride |
Extract from the above information
More
Extract from the above information |
23828-92-4 | 38 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ganciclovir |
No specific pharmacological effects mentioned
More
No specific pharmacological effects mentioned |
82410-32-0 | 36 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Tiopronin |
Animal experiments have shown that this product can reduce the increase of serum AST and ALT in the animal acute liver injury model caused by TAA (thioacetamide) and CC14 (carbon tetrachloride), and inhibit the accumulation of triglycerides caused by chronic liver injury model; it can promote liver glycogen synthesis, inhibit the increase of cholesterol, and help the recovery of serum albumin/globulin ratio.
More
Animal experiments have shown that this product can reduce the increase of serum AST and ALT in the animal acute liver injury model caused by TAA (thioacetamide) and CC14 (carbon tetrachloride), and inhibit the accumulation of triglycerides caused by chronic liver injury model; it can promote liver glycogen synthesis, inhibit the increase of cholesterol, and help the recovery of serum albumin/globulin ratio. |
1953-02-2 | 55 |